drugset / Trial / NCT06267729
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate cancer.
Timeline
- Start
- 2024-03-12
- Primary completion
- 2026-11-24
- Completion
- 2026-11-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD0754 | Cell therapy | — | Intravenous |
| Subject | AZD2287 | Diagnostic / imaging agent | — | — |